Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseasesN. Oksbjerg, Finn Sellebjerg, Susanne Dam Nielsen et al.|Multiple Sclerosis and Related Disorders|2021Cited by 67
Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977–2015: A nationwide population-based incidence studyMagnus Spangsberg Boesen, Morten Blinkenberg, Melinda Magyari et al.|Multiple Sclerosis Journal|2017Cited by 57
Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation studyMagnus Spangsberg Boesen, Alfred Peter Born, Morten Blinkenberg et al.|Developmental Medicine & Child Neurology|2018Cited by 46
Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort studyTine Iskov Kopp, Melinda Magyari, Morten Blinkenberg et al.|Multiple Sclerosis and Related Disorders|2020Cited by 41
Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort studyMagnus Spangsberg Boesen, Finn Sellebjerg, Poul Erik Jensen et al.|Multiple Sclerosis and Related Disorders|2019Cited by 41